Aetna’s board set to approve $68 billion sale to CVS Health


(Reuters) – Aetna Inc’s (AET.N) board of directors was meeting on Sunday to approve the U.S. health insurer’s sale to U.S. drugstore chain operator CVS Health Corp (CVS.N) for approximately $207 per share in cash and stock, according to people familiar with the matter.

Leave a comment

Subscribe Scroll to Top